PASG   $0.5764  -0.64% Market Closed

Passage Bio, Inc.
Total Cash 91.77M
totalCashPerShare 1.486
EBITDA -84.65M
Total Debt 26.15M
quickRatio 7.41
currentRatio 7.671
Total Revenue
debtToEquity 28.878
Revenue/Share
ROA -0.3448
ROE -0.63550997
grossProfits
freeCashflow -53.04M
operatingCashflow -70.74M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -27.23M
forwardPE -1.296
floatShares 37.10M
sharesOutstanding 61.77M
sharesShort 1.68M
sharesShortPriorMonth 1.79M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.60%
Short Ratio help_outline 6.41%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 1.466
Price To Book help_outline 0.44
earningsQuarterlyGrowth
netIncomeToCommon -76.57M
trailingEps -1.35%
forwardEps -0.50%
enterpriseToEbitda 0.32
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.23 3Q 2024
institutionsCount 53
lastUpdated Nov. 7, 2024, 3:12 a.m.